Wszolek ZK - Search Results

1

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP.

Pickles S, Gendron TF, Koike Y, Yue M, Song Y, Kachergus JM, Shi J, DeTure M, Thompson EA, Oskarsson B, Graff-Radford NR, Boeve BF, Petersen RC, Wszolek ZK, Josephs KA, Dickson DW, Petrucelli L, Cook CN, Prudencio M. Pickles S, et al. Among authors: wszolek zk. Acta Neuropathol Commun. 2022 Jul 25;10(1):107. doi: 10.1186/s40478-022-01408-6. Acta Neuropathol Commun. 2022. PMID: 35879741 Free PMC article.

2

Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.

Wszolek ZK, Gwinn-Hardy K, Wszolek EK, Muenter MD, Pfeiffer RF, Rodnitzky RL, Uitti RJ, McComb RD, Gasser T, Dickson DW. Wszolek ZK, et al. Among authors: wszolek ek. Acta Neuropathol. 2002 Apr;103(4):344-50. doi: 10.1007/s00401-001-0474-8. Epub 2001 Dec 8. Acta Neuropathol. 2002. PMID: 11904753

3

Atrophy of superior cerebellar peduncle in progressive supranuclear palsy.

Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, Dickson DW. Tsuboi Y, et al. Among authors: wszolek zk. Neurology. 2003 Jun 10;60(11):1766-9. doi: 10.1212/01.wnl.0000068011.21396.f4. Neurology. 2003. PMID: 12796528

4

Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.

Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW. Tsuboi Y, et al. Among authors: wszolek zk. Neuropathol Appl Neurobiol. 2003 Oct;29(5):503-10. doi: 10.1046/j.1365-2990.2003.00453.x. Neuropathol Appl Neurobiol. 2003. PMID: 14507342

5

Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications.

Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, Langston JW. Farrer M, et al. Ann Neurol. 2004 Feb;55(2):174-9. doi: 10.1002/ana.10846. Ann Neurol. 2004. PMID: 14755720

6

Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorder.

Uitti RJ, Calne DB, Dickson DW, Wszolek ZK. Uitti RJ, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2004 Dec;10(8):461-3. doi: 10.1016/j.parkreldis.2004.10.001. Parkinsonism Relat Disord. 2004. PMID: 15542004

7

Extending the clinicopathological spectrum of neurofilament inclusion disease.

Josephs KA, Uchikado H, McComb RD, Bashir R, Wszolek Z, Swanson J, Matsumoto J, Shaw G, Dickson DW. Josephs KA, et al. Acta Neuropathol. 2005 Apr;109(4):427-32. doi: 10.1007/s00401-004-0974-4. Epub 2005 Mar 8. Acta Neuropathol. 2005. PMID: 15754170

8

Molecular pathogenesis of Parkinson disease.

Eriksen JL, Wszolek Z, Petrucelli L. Eriksen JL, et al. Arch Neurol. 2005 Mar;62(3):353-7. doi: 10.1001/archneur.62.3.353. Arch Neurol. 2005. PMID: 15767499 Review.

9

The effect of tau genotype on clinical features in FTDP-17.

Baba Y, Tsuboi Y, Baker MC, Uitti RJ, Hutton ML, Dickson DW, Farrer M, Putzke JD, Woodruff BK, Ghetti B, Murrell JR, Boeve BF, Petersen RC, Verpillat P, Brice A, Delisle MB, Rascol O, Arima K, Dysken MW, Yasuda M, Kobayashi T, Sunohara N, Komure O, Kuno S, Sperfeld AD, Stoppe G, Kohlhase J, Pickering-Brown S, Neary D, Bugiani O, Wszolek ZK. Baba Y, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2005 Jun;11(4):205-8. doi: 10.1016/j.parkreldis.2005.01.003. Parkinsonism Relat Disord. 2005. PMID: 15878580

10

Lrrk2 pathogenic substitutions in Parkinson's disease.

Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS, Lahoz C, Wszolek ZK, Farrer MJ. Mata IF, et al. Among authors: wszolek zk. Neurogenetics. 2005 Dec;6(4):171-7. doi: 10.1007/s10048-005-0005-1. Epub 2005 Sep 17. Neurogenetics. 2005. PMID: 16172858

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

697 results

Search Page